Dental robotics in China grew rapidly after the 2017 NMPA clearance of Yakebot, the first autonomous dental implant robot approved worldwide. The segment now includes fully autonomous implant systems (Yakebot, DentalNavi, DenCore, Theta), navigation-assisted platforms (Shuzhidao, Remebot Dental), and specialty systems for hair transplantation and microsurgery where oral/maxillofacial skill overlap exists.
Clinically, dental implant robots address two recurring pain points: precise angular and depth placement in multi-implant cases, and reducing operator dependency for implants placed by generalist practitioners versus specialist oral surgeons. Studies from leading hospitals have documented placement deviation of under 1 mm in robotic cases versus 2–3 mm in manual, though broader adoption depends on procedure-time competitiveness and training pathway availability.
Market dynamics in China are shaped by the volume of private dental chains, out-of-pocket payment norms for implants, and the still-evolving reimbursement picture for complex cases. For international dental robotics manufacturers, the segment offers both established NMPA precedent and a buyer profile — large dental service organizations and teaching hospitals — that is concentrated enough to enable direct sales without extensive distributor networks.
See data methodology for how this listing is maintained.